Companies / Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc

Nasdaq: SNDXCIK 1395937NEW YORK, NY
Insider flow · last 90 daysNet sells $1.34M

Financials · FY2025

Revenue$172.35M
Net income$-285.42M
Total debt$344.03M
Cash$336.48M
Diluted EPS$-3.29
Shares outstanding89.3M

Ownership

89.3M shares outstanding · as of Jul 31, 2026
1.5%Insiders
Ownership
Insiders1.53%1,367,858
10%+ / strategic18.31%16,345,942
Institutions107.09%95,624,731
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Metzger Michael ACEOChief Executive Officer · Director
0.54%484,843
Podlesak DennisDirector
0.27%239,763
Goldan Keith A.Chief Financial Officer
0.16%139,252
Katkin KeithDirector
0.14%124,000
Jarrett JenniferDirector
0.13%114,000
Legault PierreDirector
0.13%114,000
Huber Martin H. Jr.Director
0.12%103,000
Botwood Nicholas A.J.FormerHead of R&D, CMO
0.07%60,885
Rizo AleksandraDirector
0.05%49,000

Institutional holders 238

View all →
HolderValue% of shares
BlackRock, Inc.$197.18M10.10%
Kynam Capital Management, LP$169.15M9.02%
Vanguard Group Inc$130.90M6.98%
State Street Corporation$123.69M6.34%
The Goldman Sachs Group, Inc.$119.66M6.38%
Point72 Asset Management, L.P.$102.57M5.47%
Bank of America Corp /De$98.97M5.28%
Deerfield Management Company, L.P.$88.30M4.23%
Eversept Partners, LP$69.64M3.71%
Kingdon Capital Management, L.L.C.$58.40M2.80%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 11, 2026Botwood Nicholas A.J.
Executive
SellCommon Stock$617.0K-34K
-36.02%
60,885
0.07% of shares
medium
Jun 12, 2026Botwood Nicholas A.J.
Executive
SellCommon Stock$566.6K-31K
-33.91%
60,885
0.07% of shares
medium
Jun 12, 2026Botwood Nicholas A.J.
Executive
ExerciseCommon Stock$431.7K+31K
+51.30%
92,120
0.10% of shares
low
Feb 9, 2026Metzger Michael A
CEO
SellCommon Stock$360.8K-17K
-3.37%
491,690
0.55% of shares
medium
Jun 11, 2026Botwood Nicholas A.J.
Executive
ExerciseCommon Stock$311.2K+23K
+30.99%
95,165
0.11% of shares
low
Feb 6, 2026Metzger Michael A
CEO
SellCommon Stock$152.8K-7K
-1.44%
508,849
0.57% of shares
medium
Jun 1, 2026Metzger Michael A
CEO
SellCommon Stock$130.0K-7K
-1.39%
484,843
0.54% of shares
medium
Feb 9, 2026Goldan Keith A.
Executive
SellCommon Stock$71.7K-3K
-2.37%
140,429
0.16% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—6,230,334—
State Street CorporationPassive13G—5,658,465—
Vanguard Group IncPassive13G/A—0—
State Street CorporationPassive13G—4,596,552—
Point72 Asset Management, L.P.Passive13G/A———
Vanguard Capital ManagementPassive13G—4,457,143—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SNDX——87164F105—